We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
-13.86%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$1.39B
AUM Growth
+$23.5M
Cap. Flow
+$245M
Cap. Flow %
17.64%
Top 10 Hldgs %
24.95%
Holding
4,841
New
999
Increased
1,367
Reduced
1,469
Closed
908

Sector Composition

Rank Sector Weight
1 Healthcare 6.26%
2 Financials 5.86%
3 Technology 5.03%
4 Energy 4.85%
5 Consumer Discretionary 4.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ICBK
2651
DELISTED
County Bancorp, Inc. Common Stock
ICBK
$8K ﹤0.01%
451
+249
+123% +$5.46K
CLDR
2652
DELISTED
Cloudera, Inc.
CLDR
$8K ﹤0.01%
700
-871
-55% -$11.6K
HCAP
2653
DELISTED
Harvest Capital Credit Corporation
HCAP
$8K ﹤0.01%
795
+296
+59% +$3.12K
RST
2654
DELISTED
ROSETTA STONE INC
RST
$8K ﹤0.01%
496
-195
-28% -$3.56K
PACQU
2655
DELISTED
Pure Acquisition Corp. Unit
PACQU
$8K ﹤0.01%
758
-118
-13% -$1.23K
QES
2656
DELISTED
Quintana Energy Services Inc.
QES
$8K ﹤0.01%
2,184
+1,305
+148% +$7.79K
OMN
2657
DELISTED
OMNOVA Solutions Inc.
OMN
$8K ﹤0.01%
1,065
-8,438
-89% -$68K
S
2658
DELISTED
Sprint Corporation
S
$8K ﹤0.01%
1,400
-117,016
-99% -$721K
MPVD
2659
DELISTED
Mountain Province Diamonds Inc.
MPVD
$8K ﹤0.01%
+5,900
New +$9.25K
GNBC
2660
DELISTED
Green Bancorp, Inc
GNBC
$8K ﹤0.01%
445
-1,486
-77% -$28.7K
PHIIK
2661
DELISTED
PHI, Inc. Non-Voting Common Stock
PHIIK
$8K ﹤0.01%
+4,405
New +$25.5K
BSQR
2662
DELISTED
BSQUARE Corporation
BSQR
$8K ﹤0.01%
5,037
+4,429
+728% +$9.36K
CZR
2663
DELISTED
Caesars Entertainment Corporation
CZR
$8K ﹤0.01%
1,200
+513
+75% +$4.32K
AIRG icon
2664
Airgain
AIRG
$72.4M
$7K ﹤0.01%
701
+229
+49% +$2.79K
ANIK icon
2665
Anika Therapeutics
ANIK
$287M
$7K ﹤0.01%
+204
New +$7.36K
AQST icon
2666
Aquestive Therapeutics
AQST
$494M
$7K ﹤0.01%
+1,179
New +$14.9K
ARR
2667
Armour Residential REIT
ARR
$2.36B
$7K ﹤0.01%
65
-136
-68% -$14.7K
AVTX icon
2668
Avalo Therapeutics
AVTX
$983M
$7K ﹤0.01%
1
-1
-50% -$11.1K
BELFA icon
2669
Bel Fuse Inc Class A
BELFA
$3.37B
$7K ﹤0.01%
516
+386
+297% +$6.98K
CASI
2670
DELISTED
CASI Pharmaceuticals
CASI
$7K ﹤0.01%
175
-422
-71% -$16K
CCJ icon
2671
Cameco
CCJ
$42.4B
$7K ﹤0.01%
600
-28,187
-98% -$326K
CET
2672
Central Securities Corp
CET
$1.65B
$7K ﹤0.01%
+300
New +$8.01K
COTY icon
2673
Coty
COTY
$2.48B
$7K ﹤0.01%
1,113
-3,443
-76% -$31.8K
DAN icon
2674
Dana Inc
DAN
$3.06B
$7K ﹤0.01%
507
-25,012
-98% -$379K
EMQQ icon
2675
EMQQ The Emerging Markets Internet & Ecommerce ETF
EMQQ
$273M
$7K ﹤0.01%
253
+247
+4,117% +$7.03K

Similar funds

Tower Research Capital (TRC)'s Q4 2018 Portfolio in Review

As of Q4 2018, Tower Research Capital (TRC) held 4,841 positions worth $1.39B, up 1.7% from $1.36B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Tower Research Capital (TRC) deployed $245M of net new capital in Q4 2018, opening 999 new positions and adding to 1,367 existing holdings. Its largest new stake was iShares S&P 500 Value ETF: 55,235 shares worth $5.59M.

By sector, the portfolio is most concentrated in Healthcare at 6.3% of assets, down from 6.8% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $124M trimmed.

  • Tower Research Capital (TRC)'s largest Q4 2018 buy was iShares S&P 500 Value ETF: 55,235 shares worth $5.59M.
  • Tower Research Capital (TRC) added most to iShares Russell 2000 ETF in Q4 2018, an estimated $123M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $124M.
  • Tower Research Capital (TRC) fully exited State Street Energy Select Sector SPDR ETF in Q4 2018, selling an estimated $26.3M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 25% of its $1.39B portfolio in Q4 2018.
  • Tower Research Capital (TRC) opened 999 new positions and closed 908 in Q4 2018.
  • Tower Research Capital (TRC)'s portfolio value rose 1.7% quarter-over-quarter to $1.39B.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2018, filed 14 Feb 2019.